Preclinical research at BYU could lead to development of low-cost immunotherapy
Health

Preclinical research at BYU could lead to development of low-cost immunotherapy

Stephen Atcheler
By Stephen Atcheler
November 2, 2026 1 Min Read
Comments Off on Preclinical research at BYU could lead to development of low-cost immunotherapy

PROVO — Researchers at Brigham Young University are developing new technology that could help the body fight cancer.

The technology, called MOTO-CAR, genetically modifies immune cells to recognize and attack cancer cells.

In preclinical trials, researchers saw a 90% reduction in aggressive lung cancer cells in the laboratory within 24 hours, according to the university.

Researchers, including Kim O’Neill, a professor of microbiology and molecular biology at BYU, hope the technology could eventually help treat hard-to-cure cancers.

“Our unique MOTO-CAR technology is designed to convert the patient’s immune system to recognize and fight cancer,” O’Neill said. “We hope to make the treatment more affordable so that people can use it all over the world. If successful, this technology could reduce the need for surgery, chemotherapy or radiotherapy.”

Although the research is promising, more work is needed before human trials can begin.

Gn Health

Views: 4
Stephen Atcheler
Author

Stephen Atcheler

**Stephen** is a staff journalist at **DailyVoxa**, specializing in business, finance, technology, artificial intelligence, and global markets. He is committed to delivering timely, accurate, and insightful reporting that helps readers understand the forces shaping the global economy and the rapidly evolving digital landscape.Drawing on in-depth research and credible sources, Stephen covers breaking developments, industry trends, and emerging innovations with a focus on clarity, balance, and factual accuracy. His reporting is designed to provide readers with reliable information, practical context, and thoughtful analysis without sensationalism.As a member of the DailyVoxa editorial team, Stephen follows the publication's Editorial Policy, Fact-Checking Policy, Corrections Policy, and Ethics Policy. Every article is carefully reviewed to ensure it meets the highest standards of journalistic integrity, transparency, and editorial independence.

Follow Me
Other Articles